Author Correction: Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning
Nat Biotechnol
.
2023 Nov;41(11):1655.
doi: 10.1038/s41587-023-02028-8.
Authors
Luke W Koblan
#
1
2
3
,
Mandana Arbab
#
1
2
3
,
Max W Shen
#
1
2
3
4
,
Jeffrey A Hussmann
5
6
7
8
9
,
Andrew V Anzalone
1
2
3
,
Jordan L Doman
1
2
3
,
Gregory A Newby
1
2
3
,
Dian Yang
5
7
8
9
,
Beverly Mok
1
2
3
,
Joseph M Replogle
5
7
10
11
8
9
,
Albert Xu
5
6
10
12
,
Tyler A Sisley
2
,
Jonathan S Weissman
13
14
15
16
17
,
Britt Adamson
18
19
20
21
,
David R Liu
22
23
24
Affiliations
1
Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
2
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
3
Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
4
Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA.
5
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
6
Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.
7
Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.
8
Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
9
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
10
Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA.
11
Tetrad Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
12
Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
13
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. weissman@wi.mit.edu.
14
Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA. weissman@wi.mit.edu.
15
Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA. weissman@wi.mit.edu.
16
Whitehead Institute for Biomedical Research, Cambridge, MA, USA. weissman@wi.mit.edu.
17
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. weissman@wi.mit.edu.
18
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. badamson@princeton.edu.
19
Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA. badamson@princeton.edu.
20
Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA. badamson@princeton.edu.
21
Department of Molecular Biology, Princeton University, Princeton, NJ, USA. badamson@princeton.edu.
22
Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA. drliu@fas.harvard.edu.
23
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.
24
Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.
#
Contributed equally.
PMID:
37853259
DOI:
10.1038/s41587-023-02028-8
No abstract available
Publication types
Published Erratum